-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetic-neuropathy_research-protocol.pdf
May 09, 2016 - DPN Complications treatments)
For treatment of DPN Symptoms
Study design Systematic review: We will evaluate … controlled trials, case series, case reports, and
meeting abstracts
Systematic review: We will evaluate … We will evaluate for statistical heterogeneity among studies using an I2 statistic, and
anticipate statistical
-
effectivehealthcare.ahrq.gov/sites/default/files/renal-cancer_executive.pdf
February 01, 2016 - studies
(reported in 110 articles)
Reasons for exclusion at title-abstract review level*
• Does not evaluate … Key Questions = 8,132
• Other = 5,001
Reasons for exclusion at article review level*
• Does not evaluate … Questions = 384
• Other = 701
Reasons for exclusion at Key Question applicability level*
• Does not evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-209-evidence-summary-non-pharma-chronic-pain.pdf
June 01, 2018 - We performed stratified analyses to evaluate specific
techniques within broader intervention categories … To
evaluate comparative effectiveness, exercise was chosen
as a common active comparator for all conditions … meta-analyses when poolable data were available, and
conducting stratified and sensitivity analyses to evaluate … Evidence to evaluate
how effectiveness varies by ages was limited. … trials
Documentation of coexisting conditions and factors
in trials with sufficient sample-size to evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/urinary-incontinence-update_research-protocol.pdf
June 06, 2017 - qualitatively, and, if appropriate data are
available, we may also conduct metaregression analyses to evaluate … study, patient, and
intervention features and to evaluate dose-response. … For within- and between-study
heterogeneity, we will, at a minimum, attempt to evaluate the four specific
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
November 01, 2017 - similarly
effective and safe compared with
intramuscular naloxone, but the
available studies did not evaluate … Studies should
evaluate benefits as well as important harms, including
withdrawal, agitation, aspiration … medical
examiner and hospital records to identify outcomes with
formal followup assessments, and evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_2012-12-11.pdf
January 01, 2012 - occurring in about 70% of patients with CF.
7
Additionally, the manufacturer is sponsoring a study
to evaluate … expert noted that additional clinical trials evaluating quality of life should be
performed to better evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/s116.pdf
October 01, 2007 - To evaluate whether the IV was related to other therapeu-
tic decisions that could affect mortality, … pharmacoepidemiology, prescribing
(Med Care 2007;45: S116–S122)
Observational studies are necessary to evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/s23.pdf
October 01, 2007 - journals
�Journal of American Medical Association (JAMA), British
Medical Journal (BMJ), and Lancet)� to evaluate … attack out of 1 million
OC users (for women �35 years old)” rather than using
relative terms.11
To evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/progestogens-preterm-birth_executive.pdf
September 01, 2012 - Across indications, data are
sparse to evaluate influence on near-term and long-term
maternal and infant … Across indications, data are
sparse to evaluate influence on near-term outcomes such as
neonatal mortality
-
effectivehealthcare.ahrq.gov/sites/default/files/suppl-2-user-guide-to-ocer_130129.pdf
January 01, 2011 - DAGs may be
constructed and statistical associations observed
from available data may be used to evaluate … If you were to evaluate the association
between X
1
and X
2
, you would find that X
1
does
not
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/type-2-diabetes-medications-update_research-protocol.pdf
April 06, 2010 - description of withdrawals and drop-outs.13 For the updated review, we will
also include a question to evaluate … We are also tallying studies that evaluate the following comparisons:
• Combination of a TZD and either
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure_research-protocol.pdf
April 11, 2011 - o Evaluate studies based on whether devices have been certified or approved
by the American Association … • Studies must evaluate adherence rates based on predictors (e.g., age group ≥65
vs. <65 years old
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rotator-cuff-tear_disposition-comments.pdf
October 05, 2010 - It was a
study to evaluate cuff integrity post operatively as
associated with final outcome and the … The purpose of AHRQ comparative effectiveness reviews is to
identify, evaluate and synthesize the available
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-treatment_research-protocol.pdf
November 16, 2010 - guidelines in Chapter 8 of the Cochrane Handbook for Systematic Reviews of
Interventions11 and will evaluate … We will
evaluate clinical and methodological heterogeneity by examining potential variations in participant
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-risk-assessment-genes_executive.pdf
July 01, 2012 - Evidence-Based
Practice
Evidence-based Practice
Program
The Agency for Healthcare Research and
Quality (AHRQ), through its Evidence-
based Practice Centers (EPCs), sponsors
the development of evidence reports and
technology assessments to assist public-
and private-sector organizations in their
efforts to imp…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-treatment-ssri_surveillance.pdf
January 01, 2013 - Depression SSRI Surveillance Assessment_CER 62_Low-1
CER # 62: Treatment of Depression after Unsatisfactory
Response to SSRIs
Original release date: April 2012
Surveillance Report: January 2013
Key Findings:
• All conclusions are up to date.
Summary Decision
This CER’s priority for updati…
-
effectivehealthcare.ahrq.gov/sites/default/files/coronary-artery-disease-testing_executive.pdf
March 01, 2011 - included studies, and some did not report or stratify
by pretest risk, making it difficult to fully evaluate … One apparent trend uncovered by the review is that
tests that evaluate coronary anatomy, such as CT, … There were too few studies of any given comparison to
meaningfully evaluate reporting and publication … which can
be misleading, depending on the effects on the individual
components.58 Studies did not evaluate … positive compared with
those who test negative and followup of these groups
for sufficient time to evaluate
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_surveillance.pdf
September 01, 2012 - Breast Abnormalities Update Surveillance Assessment_CER 47_Low
CER #47:
Noninvasive Diagnostic Tests for Breast
Abnormalities: Update of a 2006 Review
Original release date:
February, 2012
Surveillance Report:
January, 2013
Key Findings:
All of the key questions remain up-to-date.
Summary Deci…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-insulin_executive.pdf
September 01, 2008 - control in decreasing mortality and preventing
long-term complications, it is important to review and
evaluate … • Clinical outcomes need to be studied in order to
better evaluate the safety of premixed insulin
analogues
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment-future_research.pdf
January 01, 2014 - It may also be beneficial to establish several comparison groups to evaluate
the effects of single versus … Studies to evaluate sequential therapy should have a standardized approach to the sequential
treatment … Should alternative endpoints
be considered to evaluate outcomes in chronic
recalcitrant wounds? … date:
Not given
Estimated
primary
completion
date:
Not given
Purpose:
Pilot Study to Evaluate … Title:
Evaluate the
Impact of
Drawtex in
Venous Leg
Ulcers
Identifier(s):
NCT01319123
Start